CTRI/2025/08/093549招募中不适用
Observational Study on Nidanpanchak of Sickle Cell Disease as an Anukta Vyadhi
Dr Dhananjay V Hange1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年9月15日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- To find Nidan Panchak of Sickle Cell Disease as per Ayurved
研究概览
简要总结
In the Present Study total 100 Participants will be taken .Througly physical examination will be done then Hb electrophorerosis will be carried out .It will be helpful to classify the patient into Hb AS and Hb SS pattern as per the clinical symptoms of the patient and Dosh dushya Samurcchana nomenclutare of disease will be given on the basis of predominency of dosha .
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 5.00 Month(s) 至 25.00 Year(s)(—)
入选标准
- •Patients having age above 5 months to 25 years of HbSS pattern and patients having age above 5 month to 50 years of HbAS pattern Patients having classical signs of sickle cell disease Patients irrespective of Gender,Religion,socioeconomic status will be selected Co-operative patients.
排除标准
- •Patients is k/c/o Haemophilia,Thalassemia,G6PD deficiency.
- •Patients having other types of anemia.
- •Pregnant women and Lactating mothers.
- •Non co-operative patients.
结局指标
主要结局
To find Nidan Panchak of Sickle Cell Disease as per Ayurved
时间窗: Day 1 (one time)
次要结局
- To find the Upadravas Of Sickle cell disease as per Ayurved(one time)
研究者
Dr Dhananjay V Hange
Government Ayurved College and Hospital ,Nagpur
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Treatment of Sickle cell Anemia by Herbal medicinesCTRI/2024/11/076415Self100
招募中
1 期
Study of IADADEMSTAT for the Treatment of Sickle Cell Disease.Sickle Cell Disease2025-521838-29-00Oryzon Genomics S.A.30
尚未招募
不适用
Improving Care for Sickle Cell Disease in Tribal Communities in IndiaCTRI/2025/01/079768Department of Health Research (DHR), Ministry of Health and Family Welfare1,356
尚未招募
2/3 期
effect of Ayurvedic medicine in pain crisis management in the students with sickle cell diseaseCTRI/2025/12/099438Central Council for Research in Ayurvedic Sciences100
尚未招募
4 期
A study that helps in Observing patients suffering from Sickle Cell Disease, when given a treatment of crizanlizumab in Middle Eastcountries and India (SPOTLIGHT)CTRI/2022/06/043467ovartis Healthcare Pvt Ltd
